A Comparison of the Metabolic Effects of Zinc-Amino Acid (ZnAA) Versus Zinc Gluconate
NCT ID: NCT06348056
Last Updated: 2024-04-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
30 participants
INTERVENTIONAL
2024-01-22
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The primary aim in this study is to determine whether providing a zinc amino acid complex has a greater effect on indices of essential fatty acid desaturation compared with zinc gluconate when the zinc complexes are taken in the fasting state.
The investigators hypothesize that taking a zinc amino acid (Zn-AA) complex in a fasted state daily for two weeks has a greater effect on the Fatty Acid Desaturase 1 (FADS1) activity compared with zinc gluconate. Also, if the uptake of ionic zinc gluconate into cellular compartments is reduced in comparison to Zn-AA because the zinc gluconate is retained in the plasma, two weeks of a daily zinc gluconate will have a greater effect on fasting plasma zinc concentrations compared to a Zn- AA complex.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Efficacy and Safety of an Amino Acid Supplement in Adults
NCT05599282
Glutamate Supplementation in Young Men
NCT03425578
Effects of Dietary Amino Acids on Serum and Macrophage Atherogenicity
NCT03180775
The Effects of a Glutathione Precursor (FT061452),on Serum and Intracellular Glutathione Levels
NCT01251315
Dietary Effects of Sulfur Amino Acids
NCT00228618
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Visit 1 (Week 1, Day 1): The participants will come to Morgan Hall fasting for their first blood draw visit. They will come to the clinic after an 8-hour fast and we will collect a blood sample. They will be instructed to take their zinc starting on day 2 every morning thirty minutes prior to having their regular breakfast and to write what they eat for breakfast in their breakfast log daily. They will take the given zinc for thirteen days (days 2-14).
Visit 2 (Week 2, Day 15): The participants will come to Morgan Hall after an 8-hour fast and the investigators will collect a second blood sample. Subjects will then be given instructions for visits three and four which will take place two weeks later to allow for a washout period between the crossover studies.
Visit 3 (Week 5, Day 1): The participants will come to Morgan Hall fasting for their third blood draw visit. They will come to the clinic after an 8-hour fast and the investigators will collect a blood sample. Subjects will be instructed to take the alternate zinc starting on day 2 every morning thirty minutes prior to having their regular breakfast and to record their breakfast in their breakfast log daily. They will take the given zinc for thirteen days (days 2-14).
Visit 4: (Week 6, Day 15): The participants will come to Morgan Hall after an 8-hour fast and the investigators will collect a final fourth blood sample. The subjects' breakfast logs will be collected at this time and their participation in the study will be completed.
Study diets:
Study subjects will receive a total of 26 days of zinc (13 days of one form prior to the washout period, and then 13 of the alternate form after). They will be provided with 13 days of zinc 30 mg zinc, as zinc gluconate, and 30 mg zinc, as a zinc amino acid complex, per day. They will be randomly assigned to which form of zinc they will take for the first two weeks, taking either zinc gluconate or zinc amino acid in a fasted state. All participants will be asked to take the zinc in the fasted state at least 30 minutes before their breakfast meal. The men will log their breakfast foods, the amounts consumed, and the time they ate breakfast every day. They will be asked to maintain a steady dietary pattern over the course of the two weeks as well as maintain a steady physical activity routine.
Fasting:
No food is allowed for an 8-hour period before any of the 4 visits requiring blood sampling. Water can and should be consumed during the fast to maintain hydration and to facilitate blood collection. Any other beverages besides water are not to be consumed during the fasting period.
Blood samples (week 1, day 1; week 2, day 15; week 5, day 1; week 6, day 15.) Participants will provide a total of 4 blood samples during the study. The blood sample will be drawn by inserting a needle into a vein in their arm. Each sample will be approximately 15 ml (or 1 tablespoon); a total of 60 ml (about 1/4 cup) will be drawn for the whole study.
Laboratory analysis of samples. Blood samples will be analyzed for their total zinc content by inductively coupled plasma - optical emission spectrometry (ICP-OES) and for FADS1 activity index along with other fatty acids by liquid chromatography with tandem mass spectrometry (LC-MS/MS).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Zinc Amino Acid
The zinc in the supplement is complexed with the amino acids lysine and glutamate.
30 mg Zn Amino Acid daily for 13 days
A 30 mg zinc amino acid supplement is taken p.o. in the fasted state for 13 days.
Zinc Gluconate
The zinc in the supplement is complexed with gluconate.
30 mg Zn Gluconate daily for 13 days
A 30 mg zinc gluconate supplement is taken p.o. in the fasted state for 13 days.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
30 mg Zn Amino Acid daily for 13 days
A 30 mg zinc amino acid supplement is taken p.o. in the fasted state for 13 days.
30 mg Zn Gluconate daily for 13 days
A 30 mg zinc gluconate supplement is taken p.o. in the fasted state for 13 days.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18 to 50 years of age
* Body mass index between 18 and 30 kg/m2
* Willing to take zinc supplements provided by the study for a total of four weeks
Exclusion Criteria
* Smoking or alcohol abuse, use of illicit drugs
* Any contraindication to venipuncture such as bleeding disorders or use of blood thinners
* Those taking vitamins or supplements including minerals and omega oils, who cannot agree to stop taking the supplements two weeks prior to the study and for the duration of the study
18 Years
50 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of California, Berkeley
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of California, Berkeley
Berkeley, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022-07-15499
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.